Subha Mukherjee
About Subha Mukherjee
Subha Mukherjee is a Principal Scientist at Bristol Myers Squibb in the New York City Metropolitan Area with a strong background in organic chemistry and a focus on developing therapeutic agents for human health.
Current Role at Bristol Myers Squibb
Subha Mukherjee currently serves as a Principal Scientist at Bristol Myers Squibb, working in the New York City Metropolitan Area. In addition, they hold positions as a Senior Research Investigator I in the Greater New York City Area and as a Research Investigator II in New Brunswick, New Jersey. In these roles, they focus on developing innovative chemistry solutions to address challenging molecules in the bio-pharmaceutical industry.
Educational Background in Chemistry
Subha Mukherjee earned a Doctor of Philosophy (Ph.D.) in Chemistry from the University of Illinois at Urbana-Champaign, where they studied from 2010 to 2015. Before that, they achieved a Master’s degree in Chemistry from the Indian Institute of Technology, Kanpur, studying from 2008 to 2010. Mukherjee also holds a Bachelor's degree in Chemistry, obtained from the University of Calcutta between 2005 and 2008. This extensive educational background provides a strong foundation in organic chemistry.
Research Experience at University of Illinois
Mukherjee worked as a Graduate Researcher at the University of Illinois at Urbana-Champaign from 2010 to 2015. During this period, their research focused on using organic synthesis and molecular biology to combat antibiotic resistance and create novel antimicrobial compounds. This research aimed to leverage chemistry skills to understand biology at the molecular level and develop therapeutic agents for human health.
Focus on Synthetic Organic Chemistry
With a strong foundation in organic chemistry, Subha Mukherjee is passionate about utilizing synthetic organic chemistry to improve human health. Their career is dedicated to developing therapeutic agents by understanding biological processes at the molecular level. Mukherjee's Ph.D. research specifically targeted combating antibiotic resistance, showcasing their commitment to applying chemistry in the medical field.